Harmony Biosciences Holdings (HRMY) Retained Earnings (2019 - 2026)
Harmony Biosciences Holdings recorded quarterly Retained Earnings of -$413000.0 in Q1 2026, down 100.26% quarter-over-quarter from $160.9 million in Q4 2025, and down 100.86% year-over-year from $47.8 million in Q1 2025.
Harmony Biosciences Holdings' Retained Earnings history runs 8 years deep, the most recent figure standing at -$413000.0 for Q1 2026.
- In Q1 2026, Retained Earnings fell 100.86% year-over-year to -$413000.0; the TTM figure through Mar 2026 stood at -$413000.0 (down 100.86% YoY), while the FY2025 annual figure was $160.9 million, up 7160.97% from the prior year.
- Retained Earnings came in at -$413000.0 for Q1 2026 at Harmony Biosciences Holdings, down from $160.9 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $160.9 million in Q4 2025 to a low of -$432.1 million in Q1 2022.
- A 5-year average of -$25.3 million and a median of -$178000.0 in 2022 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings tumbled 338425.81% in 2024 and surged 37515.38% in 2025, its largest moves.
- Harmony Biosciences Holdings' Retained Earnings stood at -$151000.0 in 2022, then sank by 94785.43% to -$143.3 million in 2023, then jumped by 101.55% to $2.2 million in 2024, then surged by 7160.97% to $160.9 million in 2025, then plunged by 100.26% to -$413000.0 in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$413000.0, $160.9 million, and $357000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Harmony Biosciences Holdings | 1.83 Bn | 1.19 Bn | 170.88 Mn | -413,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -413,000.00 |
| Dec 31, 2025 | 160.90 Mn |
| Sep 30, 2025 | 357,000.00 |
| Jun 30, 2025 | 87.55 Mn |
| Mar 31, 2025 | 47.78 Mn |
| Dec 31, 2024 | 2.22 Mn |
| Sep 30, 2024 | -47.26 Mn |
| Jun 30, 2024 | -234,000.00 |
| Mar 31, 2024 | -104.94 Mn |
| Dec 31, 2023 | -143.28 Mn |
| Sep 30, 2023 | -516,000.00 |
| Jun 30, 2023 | -522,000.00 |
| Mar 31, 2023 | -31,000.00 |
| Dec 31, 2022 | -151,000.00 |
| Sep 30, 2022 | -178,000.00 |
| Jun 30, 2022 | -29,000.00 |
| Mar 31, 2022 | -432.11 Mn |
| Dec 31, 2021 | -453.60 Mn |
| Sep 30, 2021 | -476.31 Mn |
| Jun 30, 2021 | -466.69 Mn |
| Mar 31, 2021 | -480.81 Mn |
| Dec 31, 2020 | -488.20 Mn |
| Sep 30, 2020 | -487.99 Mn |
| Dec 31, 2019 | -422.86 Mn |